Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-cycloserine for Neuroplasticity and Working Memory in Schizophrenia
NCT02769936Phase 1Completed
- Sponsor
- University of California, Los Angeles
- Start
- Nov 2013
- Primary completion
- Jul 2015
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of d-cycloserine in schizophrenia (4 arms), sponsored by University of California, Los Angeles. Primary endpoints: Performance on Information Integration Learning Task, Performance on Weather Prediction Learning Task and 2 more. Started Nov 2013; status: completed.
02
Drugs
d-cycloserine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02769936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02769936.